Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald C Goff

Showing results (51-60 of 207) with videos related to

Pageof 21
Sort By:
Schizophrenia Research|January 14, 2015
The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophreniaSamuel M Cohen, Richard W Tsien, Donald C Goff, et al.
JAMA Psychiatry|September 22, 2021
Association Between Antipsychotic Use and COVID-19 Mortality Among People With Serious Mental IllnessKatlyn Nemani, Sarah Conderino, Julia Marx, et al.
Psychiatry Research|October 11, 2016
Loneliness in schizophrenia and its possible correlates. An exploratory studyFabien Trémeau, Daniel Antonius, Dolores Malaspina, et al.
Molecular Psychiatry|January 8, 2025
Quantitative magnetization transfer and g-ratio imaging of white matter myelin in early psychotic spectrum disordersYu Veronica Sui, Hilary Bertisch, Donald C Goff, et al.
The Journal of Clinical Psychiatry|October 20, 2004
Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insightOliver Freudenreich, Corinne Cather, A Eden Evins, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|October 20, 2019
Diffusion kurtosis imaging of gray matter in schizophreniaFaye F McKenna, Laura Miles, James S Babb, et al.
Psychiatric Services (Washington, D.C.)|December 4, 2003
Clinical characteristics, cognitive functioning, and criminal histories of outpatients with schizophreniaJennifer M Lafayette, W Gordon Frankle, Alison Pollock, et al.
Schizophrenia Research|June 27, 2002
D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophreniaA Eden Evins, Ed Amico, Thomas A Posever, et al.
The American Journal of Psychiatry|August 31, 2002
Intact suppression of increased false recognition in schizophreniaAnthony P Weiss, Chad S Dodson, Donald C Goff, et al.
Schizophrenia Research|July 17, 2007
Distinguishing familiarity-based from source-based memory performance in patients with schizophreniaAnthony P Weiss, Donald C Goff, Margaret Duff, et al.
Pageof 21

Showing results (51-60 of 207) with videos related to

Sort By:
Pageof 21
Schizophrenia Research|January 14, 2015
The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophreniaSamuel M Cohen, Richard W Tsien, Donald C Goff, et al.
JAMA Psychiatry|September 22, 2021
Association Between Antipsychotic Use and COVID-19 Mortality Among People With Serious Mental IllnessKatlyn Nemani, Sarah Conderino, Julia Marx, et al.
Psychiatry Research|October 11, 2016
Loneliness in schizophrenia and its possible correlates. An exploratory studyFabien Trémeau, Daniel Antonius, Dolores Malaspina, et al.
Molecular Psychiatry|January 8, 2025
Quantitative magnetization transfer and g-ratio imaging of white matter myelin in early psychotic spectrum disordersYu Veronica Sui, Hilary Bertisch, Donald C Goff, et al.
The Journal of Clinical Psychiatry|October 20, 2004
Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insightOliver Freudenreich, Corinne Cather, A Eden Evins, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|October 20, 2019
Diffusion kurtosis imaging of gray matter in schizophreniaFaye F McKenna, Laura Miles, James S Babb, et al.
Psychiatric Services (Washington, D.C.)|December 4, 2003
Clinical characteristics, cognitive functioning, and criminal histories of outpatients with schizophreniaJennifer M Lafayette, W Gordon Frankle, Alison Pollock, et al.
Schizophrenia Research|June 27, 2002
D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophreniaA Eden Evins, Ed Amico, Thomas A Posever, et al.
The American Journal of Psychiatry|August 31, 2002
Intact suppression of increased false recognition in schizophreniaAnthony P Weiss, Chad S Dodson, Donald C Goff, et al.
Schizophrenia Research|July 17, 2007
Distinguishing familiarity-based from source-based memory performance in patients with schizophreniaAnthony P Weiss, Donald C Goff, Margaret Duff, et al.
Pageof 21